Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Last Price: 8.46 - Change: -0.04 - Change %: -0.4706
Industry: Health Information ServicesFollow @stockchartsai on Twitter
In the past 30 trading days, DH has been trading in a range between $8.38 and $5.70 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
DH is trading between resistance at $9.48 about 12% to the upside and support at $7.92 -6% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $10.69, about a 26% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Definitive Healthcare Corp (DH) entered a Green zone 18 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 3.923, which is a Buy. The current analyst target price is $12.45, which gives it a potential upside of 47.16 % from the recent price of 8.46. The stock is trading 65.84% (potential upside) below its 52 week high of $14.03 and 52.98 % (potential downside) above its 52 week low of $5.53 - based on the recent price.
Definitive Healthcare Corp, together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
|Definitive Healthcare: Undervalued Vs. Peers Given Revenue Growth And Margin Expansion
Strengthening fundamentals: Definitive Healthcare shows steady revenue growth at 10% and expanding adjusted EBITDA margins. CRPO growth is slowing to a controlled rate and stabilizing, which indicates the end of client churn that took place over past 2 years. Valuation outlook: Fair price potential around $9.0, signaling a 25% upside from current $7.18.
Source: Seeking Alpha
Tue, 14 Nov 2023 10:41:59 -0500
|Definitive Healthcare Corp. (DH) Q3 2023 Earnings Call Transcript
Definitive Healthcare Corp. (DH) Q3 2023 Earnings Call Transcript
Source: Seeking Alpha
Fri, 03 Nov 2023 17:15:18 -0400
|Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)
FRAMINGHAM, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of Carrie Lazorchak as Definitive Healthcare's new Chief Revenue Officer, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted Ms. Lazorchak an inducement award consisting of 385,695 time-based restricted stock units (“RSUs”) effective November 1, 2023. This award was individually negotiated and was granted as an inducement material to Ms. Lazorchak's commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).
Fri, 03 Nov 2023 16:05:00 -0400
|Definitive Healthcare Corp. (DH) Soars 7.1%: Is Further Upside Left in the Stock?
Definitive Healthcare Corp. (DH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Source: Zacks Investment Research
Fri, 20 Oct 2023 09:46:43 -0400
|Definitive Healthcare Announces Timing of Its Third Quarter 2023 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter ended September 30, 2023, on Thursday, November 2, 2023 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.
Mon, 16 Oct 2023 16:05:00 -0400
Stock Analyzed Each Night
Easily Upload Track Your Stocks
See Lists of Stocks Starting New Trends
The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.